Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: BIOLOGICAL: tavokinogene telseplasmid|BIOLOGICAL: Pembrolizumab|DEVICE: Immunopulse|DRUG: nab paclitaxel|DRUG: gemcitabine plus carboplatin
Sponsor: OncoSec Medical Incorporated
Collaborators: Merck Sharp & Dohme LLC